Search Results - D. Amend

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P423: ADAPTING CRISPR CAS9 DROPOUT SCREENS TO IN VIVO PDX MODELS OF ACUTE LEUKEMIAS by R. Ludwig, D. Amend, E. Bahrami, I. Jeremias

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P323: STREAMLINING PRECLINICAL IN VIVO TREATMENT TRIALS BY MULTIPLEXING GENETICALLY LABELLED PDX MODELS OF SEVERAL PATIENTS IN A SINGLE MOUSE by K. Hunt, D. Amend, R. Ludwig, B. Vick, A. K. Wirth, T. Herold, I. Jeremias

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P402: MUTATIONS IN BONA FIDE ONCOGENES KRAS AND DNMT3A ARE NOT RELATED TO DEPENDENCY IN ESTABLISHED TUMORS, IN PDX MODELS OF ACUTE LEUKEMIA IN VIVO by Y. Gao, M. Ghalandary, M. Becker, D. Amend, M. Rothenberg-Thurley, K. Metzeler, I. Jeremias

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: